How do you manage severe cytarabine syndrome in AML patients, manifesting as severe hypotension, fevers, rash, and myalgias?

Topics: Hematologic Malignancies • Pediatric Oncology • Medical Oncology • Leukemia • AML • Hematology

Do you re-challenge them? If so, what pre-medications do you give? Do you dose reduce the cytarabine? Or do you switch another regimen?

Answer from: Medical Oncologist at Academic Institution

The cytarabine syndrome is a well-described (Castleberry et al. (1981) Medical and Pediatric Oncology 9:257) syndrome mediated by pro-inflammatory cytokines that are associated with fever, hypotension, rash, and often renal failure. In my experience, its most severe manifestations occur when a patie...

Comments

Medical Oncologist at Locum Tenens
Thank you, do you ever rechallenge the patient? If...

Related Questions